🔬 Exciting News in Antibody Validation! GeneTex, Inc. is thrilled to announce its partnership with YCharOS Inc., an open science initiative, aimed at enhancing antibody validation and improving data reproducibility in biomedical research. Antibodies are essential for scientific progress, yet many fail to meet validation standards, leading to unreliable results. GeneTex tackles this issue with its “5 + 1” Pillar Antibody Validation Process, ensuring high-quality, consistent antibodies that researchers can trust. Read more on our website 👉 https://lnkd.in/eKzmGZBW
关于我们
As a multinational antibody manufacturer, GeneTex’s primary goal is to provide bioscience researchers with thoroughly validated reagents to accelerate their discovery. Established in 1997 in San Antonio, Texas by scientists with expertise in clinical oncology, cancer biology, and infectious disease, the company’s initial focus was breast cancer biology and prognostic marker research. This evolved to incorporate a comprehensive portfolio of immunological reagents used by scientists probing the underlying mechanisms common to many forms of cancer. GeneTex’s catalog has since expanded to offer a broad and diverse selection of antibody products covering a full range of research areas. GeneTex is proud to offer the highest quality antibody reagents supported by extensive research, development, and validation. We are committed to the highest standards of product performance.
- 网站
-
https://www.genetex.com
GeneTex, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Irvine,CA
- 类型
- 私人持股
- 创立
- 1997
- 领域
- Antibodies for Biomedical Research、Immunoblotting Reagents、Ancillary Products for IHC, ICC/IF, ELISA, Flow Cytometry、Antibodies for Cancer Biology、DNA Repair、Virology/Infectious Disease、Cell Biology、Neuroscience、Immunology、Epigenetics和and Zebrafish Biology
地点
GeneTex, Inc.员工
动态
-
GeneTex, Inc. extends its collection of #recombinant monoclonal #antibodies against G-Protein Coupled Receptors #GPCR with the Purinergic P2Y receptors P2Y1,-2,-4,-6,-11,-12,-13,-14R. Learn more here: https://lnkd.in/eS6q9Btd #neurotransmission, #inflammation, #neurodegeneration, #autoimmune, #thrombosis, #cancer
-
-
Visit the GeneTex booth at the upcoming AACR Annual Meeting in Chicago, April 25-30. Chat with the team at booth #3113 - we look forward to connecting with you! #AACR #Antibodies #CancerResearch
-
-
We’ve partnered with GeneTex, Inc. to bring you top-quality antibodies and reagents at great prices—available at reduced Euro list prices now! 🙌 For over 25 years, GeneTex has been producing high-quality reagents used by researchers worldwide to advance biomedical research, assay development, and in vitro diagnostics. Their antibodies are validated through strict protocols for applications like WB, IP, IHC, ICC/IF, FACS, and ELISA to ensure reliable results every time. Don’t miss out on these high-performance tools—visit our website to explore the full range: https://buff.ly/SzfHA8l #GeneTex #Antibodies #LifeSciences
-
-
Back in the city where it all began — over 20 years ago, I did my very first internship in the Life Science world right here in Vienna at Biomedica. Still one of the most beautiful cities in Europe, and today, still home to one of the most trusted partners in the region: BIOMEDICA Medizinprodukte GmbH Thank you for the great meeting Stephan McGoldrick and David Pulferer and for your continued commitment and support of the GeneTex, Inc. portfolio. Your dedication to advancing life science research in Central and Southeastern Europe is truly appreciated. All GeneTex products are exclusively available through Biomedica in the following countries: Poland, Czech Republic, Slovakia, Hungary, Romania, Bulgaria, Bosnia & Herzegovina, Serbia, North Macedonia, Croatia, and Slovenia. 🇩🇪 🇹🇼 🇦🇹 🇵🇱 🇨🇿 🇸🇰 🇸🇮 🇭🇺 🇷🇸 🇧🇦 🇲🇰 🇷🇴 🇧🇬
-
-
🔬 Exciting News in Antibody Validation! GeneTex, Inc. is thrilled to announce its partnership with YCharOS Inc., an open science initiative, aimed at enhancing antibody validation and improving data reproducibility in biomedical research. Antibodies are essential for scientific progress, yet many fail to meet validation standards, leading to unreliable results. GeneTex tackles this issue with its “5 + 1” Pillar Antibody Validation Process, ensuring high-quality, consistent antibodies that researchers can trust. Read more on our website 👉 https://lnkd.in/eKzmGZBW
-
-
Back in the city where it all began — over 20 years ago, I did my very first internship in the Life Science world right here in Vienna at Biomedica. Still one of the most beautiful cities in Europe, and today, still home to one of the most trusted partners in the region: BIOMEDICA Medizinprodukte GmbH Thank you for the great meeting Stephan McGoldrick and David Pulferer and for your continued commitment and support of the GeneTex, Inc. portfolio. Your dedication to advancing life science research in Central and Southeastern Europe is truly appreciated. All GeneTex products are exclusively available through Biomedica in the following countries: Poland, Czech Republic, Slovakia, Hungary, Romania, Bulgaria, Bosnia & Herzegovina, Serbia, North Macedonia, Croatia, and Slovenia. 🇩🇪 🇹🇼 🇦🇹 🇵🇱 🇨🇿 🇸🇰 🇸🇮 🇭🇺 🇷🇸 🇧🇦 🇲🇰 🇷🇴 🇧🇬
-
-
Fantastic meeting with our amazing Italian distributor, Prodotti Gianni – the exclusive partner for GeneTex, Inc. in Italy! Huge thanks to roberta bianchi, Luigi Bondurri, and the entire Prodotti Gianni team for their incredible passion, commitment, and continued support in bringing GeneTex products to our Italian customers. All of our antibodies are available exclusively in Italy through Prodotti Gianni, and with such a dedicated and driven team representing the GeneTex brand, I’m confident we’ll achieve even greater success together. 🇮🇹 🇩🇪 🇹🇼
-
-
Today, Jonas Baeuerle from GeneTex, Inc. visited us in our Zurich office. Thank you very much for the insightful discussions and our continued successful partnership! 🤝🚀 Looking for reliable primary & secondary antibodies? Learn more about GeneTex, Inc. and their portfolio of extensively validated antibodies here👉 https://lnkd.in/dX9jVt8d
-
-
Back in France – this time visiting our French partner for GeneTex, Inc. products, CliniSciences Group right in the heart of Paris. I’m excited to continue working with Tushendan Rasiah and his amazing team in my new role at GeneTex. A big thank you to Wilfried and Perla Akiki, PhD for the very productive meeting. I’m looking forward to driving the growth of our products together in the future!
-